The short version

Scott Galloway predicted on January 1, 2024: “If 2023 was the year of GPT-4, 2024 will be the year of GLP-1.” Verdict: Called it. GLP-1 drugs, such as Ozempic, remained a dominant technology and market theme throughout 2024. The CoinGeek article (May 2024) specifically mentions Galloway elaborating on this prediction and its downstream consequences, reinforcing its prominence in the year.…

Prediction by

Scott Galloway

On January 1, 2024

“If 2023 was the year of GPT-4, 2024 will be the year of GLP-1.”

Follow-up

GLP-1 drugs, such as Ozempic, remained a dominant technology and market theme throughout 2024. The CoinGeek article (May 2024) specifically mentions Galloway elaborating on this prediction and its downstream consequences, reinforcing its prominence in the year. Numerous reports indicate GLP-1 drugs were a major disruptive force and topic of discussion in 2024, confirming the prediction's directional accuracy.

From the High Caliber AI network — see the AI for PR module in the course.